Green Cross reseeks business expansion in vaccine sector

Published: 2004-11-08 06:59:00

Updated: 2004-11-08 06:59:00

Korea Green Cross Co. is stepping up its efforts to reinitiate its vaccine business, which was turn over to KGC Vaccine Co. in 2000, industry sources said recently.

Officials at KGC Co. said the company signed a 5.0 billion transfer agreement with KGC Vaccine to acquire several vaccines, inclu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK